Ventana Medical Systems is finding it harder to say no to Roche Holding . Late Tuesday, the cancer diagnostic equipment company said it has entered into a confidentiality agreement with the Swiss ...

TUCSON, Ariz., Aug. 1, 2011 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, announced today the appointment of Mara Aspinall to the role of President, Ventana ...

Ventana Medical Systems told the Street on Wednesday that its board has decided to reject a $3 billion unsolicited takeover offer from Roche Holding , which just last month had offered $75 per ...

The board of Oro Valley-based Ventana Medical Systems Inc. on Wednesday urged shareholders to reject a $3 billion takeover bid by Roche Holding AG, calling the Swiss drug maker's $75-a-share offer ...

TUCSON, Ariz., June 3, 2013 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announced that it has signed a worldwide agreement with healthcare imaging ...

TUCSON, Ariz., Feb. 27, 2012 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for ...

Roche will make a tender offer to acquire all outstanding shares of common stock of Ventana Medical Systems for $75.00 per share in cash, or an aggregate of approximately $3 billion on a fully ...

TUCSON, Ariz., Sept. 9, 2022 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the VENTANA PD-L1 (SP263) Assay is available in countries accepting the CE mark as a companion ...

In take-over battle with Roche that has lasted almost five months, Ventana Medical Systems finally agreed to a $3.4 billion purchase price. Roche upped its bid $14.5 per share, or 19.33% ...

F. Hoffmann-La Roche Ltd The VENTANA DP 600 is Roche’s new, high-capacity slide scanner that creates high-resolution, digital images of stained tissue samples that help to diagnose cancer and ...

Roche (RHHBY) announced that the VENTANA CLDN18 RxDx Assay is the first U.S. Food and Drug Administration approved immunohistochemistry companion diagnostic for determining CLDN18 protein ...

Now they’re talking. Roche and Ventana Medical Systems have been at loggerheads for more than five months over the Swiss medical company’s efforts to buy the Arizona diagnostic firm for $3bn.